Analysis  	Analysis  	 NN	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
cytokine  	cytokine  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
larynx  	larynx  	 JJ	B-NP
squamous  	squamous  	 JJ	I-NP
cell  	cell  	 NN	I-NP
carcinoma  	carcinoma  	 NNS	I-NP
and  	and  	 CC	O
dysplasia  	dysplasia  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
Although  	Although  	 IN	O
the  	the  	 DT	O
imbalance  	imbalance  	 NN	O
of  	of  	 IN	O
cytokines  	cytokines  	 NN	B-NP
in  	in  	 IN	O
Head  	Head  	 NNP	B-NP
and  	and  	 CC	I-NP
Neck  	Neck  	 NNP	I-NP
Squamous  	Squamous  	 NNP	I-NP
Cell  	Cell  	 NNP	I-NP
Carcinoma  	Carcinoma  	 NNP	I-NP
( 	( 	 -LRB-	O
HNSCC 	HNSCC 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
well  	well  	 RB	O
known 	known 	 VBN	O
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
scarce  	scarce  	 JJ	O
data  	data  	 NNS	O
regarding  	regarding  	 VBG	O
its  	its  	 PRP$	O
occurrence  	occurrence  	 NN	O
during  	during  	 IN	O
dysplasia 	dysplasia 	 NN	B-NP
,  	,  	 ,	O
before  	before  	 IN	O
the  	the  	 DT	O
malignant  	malignant  	 JJ	O
transformation 	transformation 	 NN	B-NP
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
dysplasia  	dysplasia  	 JJ	I-NP
patients  	patients  	 NNS	I-NP
show  	show  	 VBP	O
a  	a  	 DT	O
different  	different  	 JJ	O
cytokine  	cytokine  	 JJ	B-NP
profile  	profile  	 NN	I-NP
than  	than  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
healthy  	healthy  	 JJ	O
controls 	controls 	 NNS	O
.  	.  	 .	O
Seventeen  	Seventeen  	 NNP	O
newly  	newly  	 RB	O
diagnosed 	diagnosed 	 VBN	O
,  	,  	 ,	O
untreated  	untreated  	 FW	O
larynx  	larynx  	 FW	B-NP
squamous  	squamous  	 FW	I-NP
cell  	cell  	 FW	I-NP
carcinoma  	carcinoma  	 FW	I-NP
( 	( 	 -LRB-	O
SCC 	SCC 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
six  	six  	 CD	O
laryngeal  	laryngeal  	 CD	B-NP
dysplasia  	dysplasia  	 CD	I-NP
patients  	patients  	 NNS	I-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
22  	22  	 CD	O
healthy  	healthy  	 JJ	O
controls  	controls  	 NNS	O
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
for  	for  	 IN	O
circulating  	circulating  	 VBG	B-NP
cytokines 	cytokines 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
flowcytometry  	flowcytometry  	 FW	B-NP
Th1 	Th1 	 FW	I-NP
/ 	/ 	 FW	O
Th2  	Th2  	 FW	B-NP
cytokine  	cytokine  	 FW	I-NP
array  	array  	 NN	I-NP
kit  	kit  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
quantitatively  	quantitatively  	 VB	O
measure  	measure  	 NN	B-NP
Interleukin-2  	Interleukin-2  	 NNP	I-NP
( 	( 	 -LRB-	O
IL-2 	IL-2 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
IL-4 	IL-4 	 NN	B-NP
,  	,  	 ,	O
IL-6 	IL-6 	 NNP	B-NP
,  	,  	 ,	O
IL-10 	IL-10 	 NNP	B-NP
,  	,  	 ,	O
Tumor  	Tumor  	 NNP	B-NP
Necrosis  	Necrosis  	 NNP	I-NP
Factor-α  	Factor-α  	 NNP	I-NP
( 	( 	 -LRB-	O
TNF-α 	TNF-α 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
Interferon-γ  	Interferon-γ  	 NNP	B-NP
( 	( 	 -LRB-	O
IFN-γ 	IFN-γ 	 NNP	B-NP
)  	)  	 -RRB-	O
levels 	levels 	 NNS	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
IL-8  	IL-8  	 CD	B-NP
levels  	levels  	 NNS	I-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
through  	through  	 IN	O
ELISA 	ELISA 	 NNP	B-NP
.  	.  	 .	O
IL-6 	IL-6 	 NNP	B-NP
,  	,  	 ,	O
IL-8  	IL-8  	 NNP	B-NP
and  	and  	 CC	O
IL-10  	IL-10  	 NNP	B-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
statistically  	statistically  	 RB	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
SCC  	SCC  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
IL-8  	IL-8  	 NNP	B-NP
and  	and  	 CC	O
IL-10  	IL-10  	 CD	B-NP
levels  	levels  	 NNS	I-NP
were  	were  	 VBD	O
also  	also  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
SCC  	SCC  	 NNP	B-NP
patients  	patients  	 NNS	I-NP
than  	than  	 IN	O
dysplasia  	dysplasia  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
IL-6  	IL-6  	 NNP	B-NP
and  	and  	 CC	O
IL-10  	IL-10  	 NNP	B-NP
were  	were  	 VBD	O
all  	all  	 DT	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
markedly  	markedly  	 RB	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
dysplasia  	dysplasia  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
demonstrate  	demonstrate  	 VBP	O
an  	an  	 DT	O
imbalance  	imbalance  	 NN	O
of  	of  	 IN	O
IL-6  	IL-6  	 NNP	B-NP
and  	and  	 CC	O
IL-10  	IL-10  	 NNP	B-NP
not  	not  	 RB	O
only  	only  	 RB	O
in  	in  	 IN	O
HNSCC  	HNSCC  	 NNP	B-NP
but  	but  	 CC	O
also  	also  	 RB	O
in  	in  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
dysplasia 	dysplasia 	 NN	I-NP
.  	.  	 .	O
